Viemed Healthcare, Inc. VMD
Set alert
At close · Oct 30
After hours · Oct 30, 4:33 PM ET
- YTD
- +30.15%
- 1 year
- +51.33%
- Open
- 10.00
- Prev close
- 9.95
- Mkt cap
- 368.31M
- Vol
- 119.53K
- Avg vol
- 333.21K
- EPS
- 0.36
- P/E
- 26.86
- Div yield
- 0.00%
More statistics
- Low
- 9.63
- High
- 10.03
- Forward P/E
- 19.57
- Beta
- 1.44
- Short ratio
- 1.30
- Inst. own
- 66.64%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.82
- 200-d avg
- 7.90
- 1y target
- 12.27
Key statistics
- Market cap
- 304.87M
- Enterprise value
- 308.46M
- Trailing P/E
- 31.32
- Forward P/E
- 19.57
- PEG ratio
- 0.00
- Price / sales
- 1.42
- Price / book
- 2.44
- EPS (TTM)
- 0.25
- Beta
- 1.44
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 4.86%
- Revenue (TTM)
- 214.30M
- Revenue growth
- 17.40%
- Free cash flow
- 4.84M
- Total cash
- 11.35M
- Total debt
- 7.26M
- Return on equity
- 8.88%
- Shares outstanding
- 38.94M
- Short % of float
- 0.84%
- 50-day average
- 8.82
- 200-day average
- 7.90
Analyst view
Consensus: none
- Target (low)
- 9.30
- Target (mean)
- 12.27
- Target (high)
- 15.00
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.10.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | 0.00 | 0.10 | — | — |
| Aug 7, 2024 | Jun 1, 2024 | 0.00 | 0.04 | — | — |
| May 6, 2024 | Mar 1, 2024 | 0.00 | 0.04 | — | — |
| Mar 6, 2024 | Dec 1, 2023 | 0.00 | 0.09 | — | — |
| Nov 1, 2023 | Sep 1, 2023 | 0.00 | 0.07 | — | — |
| Aug 9, 2023 | Jun 1, 2023 | 0.00 | 0.06 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2021 | RBC Capital | main | — | Outperform |
| Mar 5, 2021 | RBC Capital | init | — | Outperform |
About Viemed Healthcare, Inc.
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- viemed.com
News
- Viemed Healthcare Maps Growth in Home Respiratory Care, Sleep and Maternal Health
- Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
- Do Options Traders Know Something About Viemed Stock We Don't?
- Viemed Healthcare, Inc. to Present at the 20th Annual LD Micro Main Event
- Viemed Healthcare: Improving Capital Efficiency Creates A Strong Buy Opportunity
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands
- Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14
- Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on VMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAMBRE JEROME RICHARD II | Officer | Conversion of Exercise of derivative security | May 8, 2024 | 74,457 |
| DOBBS RANDY EDWARD | Director | Sale | Nov 12, 2024 | 107,706 |
| FITZGERALD TRAE PAUL | Chief Financial Officer | Conversion of Exercise of derivative security | May 8, 2024 | 66,428 |
| FRAZIER WILLIAM | Officer and Director | Conversion of Exercise of derivative security | Aug 22, 2024 | 67,808 |
| GREENSTEIN BRUCE D | Director | Conversion of Exercise of derivative security | Aug 22, 2024 | 76,651 |
| HELTZ SABRINA ANN BOURGEOIS | Director | Conversion of Exercise of derivative security | Aug 22, 2024 | 51,759 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Thrivent Financial For Lutherans | 8.80% | 3,425,693 | 26.82M | Sep 29, 2024 |
| Blackrock Inc. | 7.65% | 2,978,128 | 23.32M | Sep 29, 2024 |
| Wasatch Advisors LP | 4.75% | 1,848,884 | 14.48M | Sep 29, 2024 |
| Vanguard Group Inc | 4.65% | 1,810,401 | 14.18M | Sep 29, 2024 |
| Forager Capital Management, LLC | 4.41% | 1,717,488 | 13.45M | Sep 29, 2024 |
| Kent Lake PR LLC | 3.34% | 1,300,000 | 10.18M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Thrivent Small Cap Stock Fund | 5.75% | 2,236,995 | 17.52M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.33% | 908,456 | 7.11M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.14% | 834,970 | 6.54M | Oct 30, 2024 |
| Wasatch Micro-Cap Value Fund | 2.05% | 797,000 | 6.24M | Sep 29, 2024 |
| Thrivent Small Cap Stock Portfolio | 1.96% | 764,728 | 5.99M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.51% | 587,246 | 4.60M | Sep 29, 2024 |